Lenvima (lenvatinib) — Medica
Thymic carcinoma
Initial criteria
- age ≥ 18 years
- Patient has tried at least one chemotherapy regimen (e.g., carboplatin plus paclitaxel, cisplatin, doxorubicin plus cyclophosphamide, cisplatin plus etoposide)
Approval duration
1 year